DOMS Industries Ltd - 544045 - Announcement under Regulation 30 (LODR)-Acquisition
Disclosure of Events/ Information under Regulation 30 of (SEBI) LODR Regulations, 2015 - Acquisition of Uniclan Healthcare Private Limited12-08-2024
DOMS Industries Ltd - 544045 - Announcement under Regulation 30 (LODR)-Acquisition
Disclosure of Events/ Information under Regulation 30 of (SEBI) LODR Regulations, 2015 - Acquisition of Uniclan Healthcare Private LimitedDOMS Industries Ltd - 544045 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Result Release in relation to the Unaudited Financial Results for the quarter ended June 30, 2024DOMS Industries Ltd - 544045 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation in relation to the Unaudited Financial Results for the quarter ended June 30, 2024DOMS Industries Ltd - 544045 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Alteration of Main object clause of Memorandum of Association of the CompanyDOMS Industries Ltd - 544045 - Record Date For Final Dividend
Fixed Record date for entitlement of final dividendDOMS Industries Ltd - 544045 - Unaudited Financial Results For The Quarter Ended June 30, 2024
Unaudited Financial Results for the quarter ended June 30, 2024 and fixed record date and Annual General MeetingDOMS Industries Ltd - 544045 - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 12, 2024
Unaudited financial results for the quarter ended June 30, 2024 and fixed record date and Annual General Meeting.DOMS Industries Ltd - 544045 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call under the SEBI (LODR) Regulations, 2015DOMS Industries Ltd - 544045 - Board Meeting Intimation for Board Meeting Intimation For Consideration Of Unaudited (Standalone And Consolidated) Financial Results For The Quarter Ended June 30, 2024
DOMS Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 ,inter alia, to consider and approve Unaudited (Standalone and Consolidated) Financial Results for the quarter ended June 30, 2024